Switch to:

Verici Dx (OTCPK:VRCDF) Beta

: N/A (As of Today)
View and export this data going back to 2021. Start your Free Trial

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2023-03-23), Verici Dx's Beta is Not available.

Verici Dx Beta Historical Data

The historical data trend for Verici Dx's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verici Dx Annual Data
Trend Dec20 Dec21
- -

Verici Dx Semi-Annual Data
Jun21 Dec21 Jun22
Beta - - -

Competitive Comparison

For the Diagnostics & Research subindustry, Verici Dx's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verici Dx Beta Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Verici Dx's Beta distribution charts can be found below:

* The bar in red indicates where Verici Dx's Beta falls in comparison to its industry or sector. The grey bar indicates the Beta's extreme value range as defined by GuruFocus.

Verici Dx Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Verici Dx  (OTCPK:VRCDF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Verici Dx Beta Related Terms

Thank you for viewing the detailed overview of Verici Dx's Beta provided by Please click on the following links to see related term pages.

Verici Dx (OTCPK:VRCDF) Business Description

Verici Dx logo
Traded in Other Exchanges
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies which will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialisation: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels.

Verici Dx (OTCPK:VRCDF) Headlines

No Headlines